In this newly created senior leadership role, Robey directs all marketing and communications strategies and activities to strengthen the FCS brand and support the company’s long-term growth initiatives.
The study found that 1.05% of participants had developed antibodies against COVID-19 as the result of previous infection, concluding that patients are at low risk for acquiring the coronavirus while receiving care from community oncology providers.
FCS performed strongly in all areas of the survey. Rankings were highest for providers and communication with patients — both of which well exceeded statewide and national averages.
It will provide expanded treatment space for patients, with 18 exam rooms, 50 infusion chairs and on-site imaging, laboratory, pharmacy and care management services. Scheduled to open in November 2021, the 20,250-square-foot building will replace the two existing FCS clinic locations in Manatee County.
Fort Myers, Fla., Jan. 12, 2021 — Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified gynecologic oncologist Jessica Stine, MD. She is caring for patients at the FCS New Port Richey location at 8763 River Crossing Blvd., New Port Richey, FL and in Wesley Chapel at 2391 Oak Myrtle Lane, Wesley Chapel, FL.
Fort Myers, Fla., Jan. 12, 2021 — Florida Cancer Specialists & Research Institute (FCS) medical oncologist Michael McCleod, DO, FACOI, who practices in Fort Myers and Cape Coral, is co-author of a recently published study that evaluates and compares best supportive care (BSC) alone versus BSC plus nab-paclitaxel for squamous non-small-cell lung cancer (NSCLC). Published in the January 2021 issue of Clinical Lung Cancer, the study stated that while there have been “… significant treatment advances for patients with advanced non-small-cell lung cancer (NSCLC) …” in recent years, “… the number of treatment options for patients with squamous histologic features has lagged behind that for patients with non-squamous histologic features.”
FCS Top News Updates
FCS Signals Next Chapter of Growth With Planned Leadership Transition and Focus on Innovation
Florida Cancer Specialists Names Michelle Robey as Vice President of MarketingIn this newly created senior leadership role, Robey directs all marketing and communications strategies and activities to strengthen the FCS brand and support the company’s long-term growth initiatives.
New Study Finds Low Prevalence of COVID-19 Infection Among Community Oncology Care ProvidersThe study found that 1.05% of participants had developed antibodies against COVID-19 as the result of previous infection, concluding that patients are at low risk for acquiring the coronavirus while receiving care from community oncology providers.
Cancer Patients Give Florida Cancer Specialists & Research Institute High Marks in Patient Satisfaction SurveysFCS performed strongly in all areas of the survey. Rankings were highest for providers and communication with patients — both of which well exceeded statewide and national averages.
Florida Cancer Specialists & Research Institute Breaks Ground for New Cancer Center in BradentonIt will provide expanded treatment space for patients, with 18 exam rooms, 50 infusion chairs and on-site imaging, laboratory, pharmacy and care management services. Scheduled to open in November 2021, the 20,250-square-foot building will replace the two existing FCS clinic locations in Manatee County.
Innovative Procedure to Enhance Treatment For Prostate CancerInnovation proven to minimize potential side effects for prostate cancer patients who receive radiation therapy.
Florida Cancer Specialists & Research Institute Welcomes Dr. Jessica StineFort Myers, Fla., Jan. 12, 2021 — Florida Cancer Specialists & Research Institute (FCS) welcomes Board-certified gynecologic oncologist Jessica Stine, MD. She is caring for patients at the FCS New Port Richey location at 8763 River Crossing Blvd., New Port Richey, FL and in Wesley Chapel at 2391 Oak Myrtle Lane, Wesley Chapel, FL.